These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2689396)

  • 1. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.
    Herman TS; Jochelson MS; Teicher BA; Scott PJ; Hansen J; Clark JR; Pfeffer MR; Gelwan LE; Molnar-Griffin BJ; Fraser SM
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1273-9. PubMed ID: 2689396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma.
    Bornstein BA; Zouranjian PS; Hansen JL; Fraser SM; Gelwan LA; Teicher BA; Svensson GK
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):79-85. PubMed ID: 7677990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours.
    Bornstein BA; Herman TS; Hansen JL; Buswell L; Zouranjian PS; Fraser SM; Teicher BA; Svensson GK; Coleman CN
    Int J Hyperthermia; 1995; 11(4):489-99. PubMed ID: 7594803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study.
    Amichetti M; Graiff C; Fellin G; Pani G; Bolner A; Maluta S; Valdagni R
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):801-7. PubMed ID: 8344849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy.
    Green DM; Burton GV; Cox EB; Hanson D; Moore J; Oleson JR
    Int J Hyperthermia; 1989; 5(1):13-21. PubMed ID: 2646381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment.
    Myerson RJ; Straube WL; Moros EG; Emami BN; Lee HK; Perez CA; Taylor ME
    Int J Hyperthermia; 1999; 15(4):251-66. PubMed ID: 10458566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation.
    Herman TS; Teicher BA
    Int J Hyperthermia; 1994; 10(3):443-9. PubMed ID: 7930812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hyperthermia for advanced tumors: a clinical study of 353 patients.
    Petrovich Z; Langholz B; Gibbs FA; Sapozink MD; Kapp DS; Stewart RJ; Emami B; Oleson J; Senzer N; Slater J
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):601-7. PubMed ID: 2646259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical hyperthermia: results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy.
    Manning MR; Cetas TC; Miller RC; Oleson JR; Connor WG; Gerner EW
    Cancer; 1982 Jan; 49(2):205-16. PubMed ID: 6274503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local superficial hyperthermia in combination with low-dose radiation therapy for palliation of locally recurrent breast carcinoma.
    Dragovic J; Seydel HG; Sandhu T; Kolosvary A; Blough J
    J Clin Oncol; 1989 Jan; 7(1):30-5. PubMed ID: 2642537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
    Slotman GJ; Doolittle CH; Glicksman AS
    Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.